Document:

WARRANT
      NUMBER ____

     

    THE
      SECURITIES REPRESENTED HEREBY AND THE SECURITIES WHICH MAY BE ISSUED UPON
      EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
      AND
      HAVE
      BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH,
      THE
      SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED
      WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF
      COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT
      REQUIRED UNDER THE SECURITIES ACT OF 1933.

     

    UNLESS
      PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT
      TRADE THE SECURITY BEFORE THE DATE THAT IS FOUR MONTHS AND A DAY AFTER THE
      LATER
      OF (I) [insert issuance date of warrants], AND (II) THE DATE THE ISSUER BECAME
      A
      REPORTING ISSUER IN ANY PROVINCE OR TERRITORY. [FOR CANADIAN WARRANT
      HOLDERS]

     

    WARRANT
      AGREEMENT

     

    WARRANT
      AGREEMENT (this “Agreement”), dated as of _______ __, 2007, by and between
      RxElite Holdings Inc. (the “Company”), and ______________________ (the “Warrant
      Holder”).

     

    WITNESSETH

     

    WHEREAS,
      the parties have entered into that certain Stock Purchase Agreement, dated
      as of
      January 19, 2007, by and between the Company and the Warrant Holder (the
“Purchase Agreement”); and

     

    WHEREAS,
      pursuant to the Purchase Agreement, the Company
      has agreed to issue
      to
      the Warrant Holder a warrant (the “Warrant”) to purchase __________ shares of
      the Company’s common stock, par value US$.001 per share (the “Common Stock”),
      subject to the terms set forth herein.

     

    NOW,
      THEREFORE, in consideration of the foregoing and the mutual covenants and
      promises contained herein, and for other good and valuable consideration, the
      receipt and sufficiency of which are hereby acknowledged, the parties agree
      as
      follows:

     

    1. Warrant;
      Call.
      (a) The
      Company hereby grants to the Warrant Holder, subject to the terms set forth
      herein, the right to purchase at any time during the term commencing on the
      date
      hereof and ending at 5:30 p.m., New York time, on the second (2nd)
      anniversary of the date hereof (the “Expiration Date”) __________ shares of
      Common Stock (the “Shares”), at an initial exercise price of US$0.85 per share,
      subject to adjustment as provided in Section
      3
      hereof
      (as in effect from time to time, the “Exercise Price”).

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) Should
      the closing bid price of one share of the Company’s Common Stock be or exceed US
      $2.20 per share for 20 consecutive trading days, then, at the election of the
      Company (which shall be made in the form of a notice to the Warrant Holder),
      this Warrant shall automatically be exercised. The Warrant Holder will take
      all
      steps necessary to implement the preceding sentence. If this Warrant shall
      not
      be exercised by the Warrant Holder within 5 calendar days’ after the Company’s
      notice described in the first sentence of this clause (b), then this Warrant
      shall immediately expire and be of no further force and effect.

     

    2. Exercise
      of Warrant.
      

     

    2.1 Exercise.
      The
      Warrant may be exercised by the Warrant Holder, in whole or in part, by
      delivering the Notice of Exercise purchase form, attached as Exhibit
      A
      hereto
      (the “Notice of Exercise”), duly executed by the Warrant Holder to the Company
      at its principal office, or at such other office as the Company may designate,
      accompanied by payment, in cash or by wire transfer or check payable to the
      order of the Company, of the amount obtained by multiplying the number of Shares
      designated in the Notice of Exercise by the Exercise Price (the “Purchase
      Price”). 

     

    2.2 Issuance
      of Certificates.
      As soon
      as practicable after the exercise of the Warrant (in whole or in part) in
      accordance with Section
      2.1
      hereof,
      the Company, at its expense, shall cause to be issued in the name of and
      delivered to the Warrant Holder (i) a certificate or certificates for the number
      of fully paid and non-assessable Shares to which the Warrant Holder shall be
      entitled upon such exercise and (if applicable) (ii) a new warrant agreement
      of
      like tenor to purchase all of the Shares that may be purchased pursuant to
      the
      portion, if any, of the Warrant not exercised by the Warrant Holder. The Warrant
      Holder shall for all purposes be deemed to have become the holder of record
      of
      such Shares on the date on which the Notice of Exercise and payment of the
      Purchase Price in accordance with Section
      2.1
      hereof
      were delivered and made, respectively, irrespective of the date of delivery
      of
      such certificate or certificates, except that if the date of such delivery,
      notice and payment is a date when the stock transfer books of the Company are
      closed, such person shall be deemed to have become the holder of record of
      such
      Shares at the close of business on the next succeeding date on which the stock
      transfer books are open.

     

    3. Adjustments.

     

    3.1 Stock
      Splits, Stock Dividends and Combinations.
      If the
      Company at any time subdivides the outstanding shares of the Common Stock or
      issues a stock dividend (in Common Stock) on the outstanding shares of the
      Common Stock, the Exercise Price in effect immediately prior to such subdivision
      or the issuance of such stock dividend shall be proportionately decreased,
      and
      the number of Shares subject hereto shall be proportionately increased, and
      if
      the Company at any time combines (by reverse stock split or otherwise) the
      outstanding shares of Common Stock, the Exercise Price in effect immediately
      prior to such combination shall be proportionately increased, and the number
      of
      Shares subject hereto shall be proportionately decreased, effective at the
      close
      of business on the date of such subdivision, stock dividend or combination,
      as
      the case may be.

     

    3.2 Merger
      or Consolidation.
      In the
      case of any consolidation of the Company with, or merger of the Company with
      or
      into another entity (other than a consolidation or merger which does not result
      in any reclassification or change of the outstanding capital stock of the
      Company), the entity formed by such consolidation or merger shall execute and
      deliver to the Warrant Holder a supplemental warrant agreement providing that
      the Warrant Holder of the Warrant then outstanding or to be outstanding shall
      have the right thereafter (until the expiration of such Warrant) to receive,
      upon exercise of such Warrant, the kind and amount of shares of capital stock
      and other securities and property receivable upon such consolidation or merger
      by a holder of the number of Shares for which such Warrant might have been
      exercised immediately prior to such consolidation or merger. Such supplemental
      warrant agreement shall provide for adjustments which shall be identical to
      the
      adjustments provided in Section
      3.1
      hereof.
      This Section
      3.2 shall
      similarly apply to successive consolidations or mergers.

     

    
      
        
        

      

      
        -2-

        
          

        

      

      
        
        

      

    

     

    3.3. Certificate
      as to Adjustments.
      Upon
      the occurrence of each adjustment or readjustment of the Exercise Price pursuant
      to this Section
      3,
      the
      Company, at its expense, shall promptly compute such adjustment or readjustment
      of the Exercise Price in accordance with the terms hereof and furnish to each
      Holder of a Warrant a certificate setting forth such adjustment or readjustment
      and showing in detail the facts upon which such adjustment or readjustment
      is
      based, including a statement of (i) the Exercise Price in effect immediately
      prior to such adjustment or readjustment and (ii) the number of shares of Common
      Stock and the amount, if any, of other securities or property that at the time
      would be received upon the exercise of the Warrant. The Company shall, upon
      the
      written request at any time of any Holder of a Warrant, furnish or cause to
      be
      furnished to such Holder a like certificate setting forth (x) all adjustments
      and readjustments of the Exercise Price since the Original Issue Date and (y)
      the Exercise Price then in effect.

     

    4. Transfers.

     

    4.1 General.
      Warrant
      Holder hereby acknowledges and agrees that the sale, transfer, assignment or
      pledge of this Warrant and the Shares shall be governed by the Purchase
      Agreement. 

     

    4.2 Warrant
      Register.
      The
      Company will maintain a register containing the names and addresses of the
      Warrant Holders of the Warrant. Until any transfer of Warrant in accordance
      with
      the Purchase Agreement is reflected in the warrant register, the Company may
      treat the Warrant Holder as the absolute owner hereof for all purposes. Any
      Warrant Holder may change such Warrant Holder’s address as shown on the warrant
      register by written notice to the Company requesting such change.

     

    5. No
      Fractional Shares.
      Any
      adjustment in the number of Shares purchasable hereunder shall be rounded to
      the
      nearest whole share.

     

    6. Covenants
      as to the Shares.
      The
      Company covenants and agrees that the Shares issuable upon exercise of the
      Warrant, will, upon issuance in accordance with the terms hereof, be duly and
      validly issued and outstanding, fully paid and nonassessable, with no personal
      liability attaching to the ownership thereof, and free from all taxes, liens
      and
      charges with respect to the issuance thereof imposed by or through the Company;
      provided,
      however,
      that
      the Company shall not be required to pay any tax that may be payable in respect
      of any transfer involved in the issuance and delivery of any certificates in
      respect of such shares in a name other than that of the Warrant Holder and
      the
      Company shall not be required to issue or deliver such certificates unless
      or
      until the person(s) requesting the issuance thereof shall have paid to the
      Company the amount of such tax or it shall be established to the satisfaction
      of
      the Company that such tax has been paid. The Company further covenants and
      agrees that the Company will at all times have authorized and reserved, free
      from preemptive rights imposed by or through the Company, a sufficient number
      of
      shares of Common Stock to provide for the exercise of the rights represented
      under this Agreement.

     

    
      
        
        

      

      
        -3-

        
          

        

      

      
        
        

      

    

     

    7. Legend.
      Any
      certificate evidencing the Shares issuable upon exercise hereof will bear the
      legend set forth in the Purchase Agreement. 

     

    8. Rights
      Applicable to the Warrant Shares.
      The
      parties hereby acknowledge and agree that the Shares, when issued in accordance
      with the terms hereof, shall be “Registrable Securities” pursuant to the
      Registration Rights Agreement (as such term is defined in the Purchase
      Agreement).

     

    9. Dividends
      and Other Distributions.
      In the
      event that the Company shall, at any time prior to the exercise of all Warrants,
      declare a dividend (other than a dividend consisting solely of shares of Common
      Stock) or otherwise distribute to its stockholders any assets, properties,
      rights, evidence of indebtedness, securities (other than shares of Common
      Stock), whether issued by the Company or by another person, or any other thing
      of value, the Company shall give the Warrant Holder 10 calendar days’ prior
      written notice of such proposed dividend or distribution. 

     

    10. Miscellaneous.

     

    10.1 Waivers
      and Amendments.
      This
      Agreement or any provisions hereof may be changed, waived, discharged or
      terminated only by a statement in writing signed by the Company and by the
      Warrant Holder.

     

    10.2 Governing
      Law.
      All
      questions concerning the construction, validity, enforcement and interpretation
      of this Agreement shall be governed by and construed and enforced in accordance
      with the internal laws of the State of Idaho, without regard to the principles
      of conflicts of law thereof. Each party agrees that all legal proceedings
      concerning the interpretations, enforcement and defense of the transactions
      contemplated by this Agreement (whether brought against a party hereto or its
      respective affiliates, directors, officers, shareholders, employees or agents)
      shall be commenced exclusively in the state and federal courts sitting in the
      City of Boise, Idaho. Each party hereto hereby irrevocably submits to the
      exclusive jurisdiction of the state and federal courts sitting in the City
      of
      Boise, Idaho for the adjudication of any dispute hereunder or in connection
      herewith or with any transaction contemplated hereby or discussed herein
      (including with respect to the enforcement of this Agreement), and hereby
      irrevocably waives, and agrees not to assert in any suit, action or proceeding,
      any claim that it is not personally subject to the jurisdiction of any such
      court. Each party hereto hereby irrevocably waives personal service of process
      and consents to process being served in any such suit, action or proceeding
      by
      delivering a copy thereof via overnight delivery (with evidence of delivery)
      to
      such party at the address in effect for notices to it under this Agreement
      and
      agrees that such service shall constitute good and sufficient service of process
      and notice thereof. Nothing contained herein shall be deemed to limit in any
      way
      any right to serve process in any manner permitted by law. Each party hereto
      hereby irrevocably waives, to the fullest extent permitted by applicable law,
      any and all right to trial by jury in any legal proceeding arising out of or
      relating to this Agreement or the transactions contemplated hereby. If either
      party shall commence an action or proceeding to enforce any provisions of this
      Agreement, then the prevailing party in such action or proceeding shall be
      reimbursed by the other party for its attorneys fees and other costs and
      expenses incurred with the investigation, preparation and prosecution of such
      action or proceeding.

     

    
      
        
        

      

      
        -4-

        
          

        

      

      
        
        

      

    

     

    10.3 Notices.
      All
      notices and other communications hereunder shall be made in accordance with
      the
      Purchase Agreement.

     

    10.4 Headings.
      The
      headings in this Agreement are for convenience of reference only, and shall
      not
      limit or otherwise affect the terms hereof.

     

    10.5 Closing
      of Books.
      The
      Company will at no time close its transfer books against the transfer of any
      Shares issued or issuable upon the exercise of the Warrant in a manner that
      interferes with the timely exercise of the Warrant.

     

    10.6 No
      Rights or Liabilities as a Stockholder.
      This
      Agreement shall not entitle the Warrant Holder hereof to any voting rights
      or
      other rights as a stockholder of the Company with respect to the Shares prior
      to
      the exercise of the Warrant. No provision of this Agreement, in the absence
      of
      affirmative action by the Warrant Holder to purchase the Shares, and no mere
      enumeration herein of the rights or privileges of the Warrant Holder, shall
      give
      rise to any liability of such Holder for the Exercise Price or as a stockholder
      of the Company, whether such liability is asserted by the Company or by
      creditors of the Company.

     

    10.7 Successors.
      All the
      covenants and provisions of this Agreement shall be binding upon and inure
      to
      the benefit of the parties hereto and their respective successors and permitted
      assigns and transferees.

     

    11.8 Severability.
      If any
      provision of this Agreement shall be held to be invalid and unenforceable,
      such
      invalidity or unenforceability shall not affect any other provision of this
      Agreement.

     

    [SIGNATURE
      PAGE FOLLOWS]

     

    
      
        
        

      

      
        -5-

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF, the undersigned have caused this Agreement to be executed
      as of
      the date first written above.

    

    

    RxELITE
      HOLDINGS INC.

    

    

    By:
      ____________________________________       

    Name:

    Title:

    

    

    ________________________________________

    (name
      of
      Warrant Holder)

    

    

    

    By:
      ______________________________________

                
      Name:

    Title:

    

    
      
        
        

      

      
        -6-

        
          

        

      

      
        
        

      

    

    EXHIBIT
      A

     

    NOTICE
      OF EXERCISE

     

    (To
      be
      signed only on exercise of Warrant)

     

    Dated:________________________

     

    To: RxElite
      Holdings Inc.

     

    The
      undersigned, pursuant to the provisions set forth in the attached Warrant
      Agreement, hereby irrevocably elects to: 

     

    purchase
      _____ shares of Common Stock covered by such Warrant Agreement and herewith
      makes a cash payment of US$_____________, representing the full purchase price
      for such shares at the price per share provided for in such Warrant
      Agreement.

     

    Please
      issue a certificate or certificates representing such shares of Common Stock
      in
      the name of the undersigned or in such other name as is specified
      below.

     

    Signature:___________________________

     

    Name
      (print):________________________

     

    Title
      (if
      applicable):____________________

     

    Company
      (if applicable):_________________FIRST
        AMENDMENT TO

      WARRANT
        AGREEMENT

       

      This
        First Amendment to Warrant Agreement (this “Amendment”)
        is
        entered into as of July [ _ ], 2007 by and between Southridge Technology
        Group,
        Inc., a Delaware corporation (“Pubco”)
        that
        will acquire all of the issued and outstanding capital stock of RxElite Holdings
        Inc., a Delaware corporation (“RxElite”)
        and
        succeed to the business of RxElite as its sole line of business (on a combined,
        post-acquisition basis, Pubco, and its subsidiary, RxElite, are collectively
        referred to as “Seller”),
        and
        the Warrant Holder (as defined below). This Amendment amends that Warrant
        Agreement (the “Warrant”),
        dated
        as of January 19, 2007 by and among RxElite and the Warrant Holder (as defined
        therein). Capitalized terms not otherwise defined herein shall have the meanings
        given in the Warrant.

       

      RECITALS

       

      WHEREAS,
        RxElite
        previously issued the Warrant to the Warrant Holder pursuant to the Stock
        Purchase Agreement (the “Agreement”),
        dated
        as of January 19, 2007 by and among the Company and the persons and entities
        listed on Exhibit
        A
        thereto;

       

      WHEREAS,
        certain
        purchasers acquired from RxElite common stock and warrants to purchase shares
        of
        the common stock in a subsequent private offering of securities pursuant
        to
        certain Stock Purchase Agreements each dated as of July [ _ ], 2007 (the
        “New
        Purchase Agreements”);
        

       

      WHEREAS,
        the
        Warrant Holder and RxElite wish to amend the Warrant to provide substantially
        the same terms to the Warrant Holder as are contained in the warrants to
        purchase common stock issued pursuant to the New Purchase Agreements effective
        with and conditioned upon the acquisition referred to above such that Pubco
        shall assume all obligations and rights of RxElite hereunder; and

       

      WHEREAS,
        Section
        10.1 of the Warrant provides that it may be amended with the written consent
        of
        each party thereto.

       

      NOW,
        THEREFORE, in
        consideration of the foregoing and of the mutual promises and covenants set
        forth herein, the parties agree as follows:

       

      1. PAR
        VALUE. 
        Each
        reference to the par value per share of the Company’s Common Stock contained in
        the Warrant is hereby deleted.

       

      2. AMENDMENT
        OF SECTION 1. 
        Section
        1 of the Warrant is hereby deleted and replaced in its entirety by the
        following:

       

      1. Warrant;
        Call.

       

      (a) The
        Company hereby grants to the Warrant Holder, subject to the terms set forth
        herein, the right to purchase at any time during the term commencing on the
        date
        that the Company has amended its certificate of incorporation to increase
        its
        authorized capital to permit the exercise of all of the Warrants (the
“Commencement Date”) and ending at 5:30 p.m., New York time, on the second (2nd)
        anniversary of the Commencement Date hereof (the “Expiration Date”) __________
        shares of Common Stock (the “Shares”), at an initial exercise price of US $0.85
        per share, subject to adjustment as provided in Section 3 hereof (as in effect
        from time to time, the “Exercise Price”).

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

         

      

      (b) Notwithstanding
        anything herein to the contrary, if after the Commencement Date, the closing
        bid
        price of the Common Stock equals or exceeds US $2.20 per share for 20
        consecutive trading days, which period shall have commenced only after the
        Commencement Date (such period the “Threshold Period”), the Company may, within
        2 trading days after the end of any such Threshold Period, deliver a written
        notice to the Warrant Holder (a “Forced Exercise Notice”) to cause the Warrant
        Holder to exercise this Warrant in its entirety within five trading days
        (such
        fifth trading day, the “Forced Exercise Date”), after which date this Warrant
        shall immediately expire and be of no further force and effect, provided,
        however, that the Registration Statement (as defined in the Registration
        Rights
        Agreement) must have been continuously effective during the Threshold Period.
        The Company may not deliver a Forced Exercise Notice, and any Forced Exercise
        Notice delivered by the Company shall not be effective, unless the Registration
        Statement covering the resale of the Shares remains effective on each trading
        day occurring during the applicable Threshold Period through and including
        the
        Forced Exercise Date.

       

      3. AMENDMENT
        OF SECTION 3.2. 
        The last
        sentence of Section 3.2 of the Warrant is hereby deleted in its
        entirety.

       

      4. NEW
        SECTION 3.4. 
        New
        Section 3.4 of the Warrant is hereby inserted and reads in its entirety as
        follows:

       

      Adjustment
        Upon Issuance of Common Stock.
        If the
        Company, at any time prior to the earlier of (i) the Effective Date or (ii)
        the
        one-year anniversary of the Closing Date (as defined in the Purchase Agreement),
        shall sell or grant any option to purchase, or sell or grant any right to
        reprice its securities, or otherwise dispose of or issue (or announce any
        offer,
        sale, grant or any option to purchase or other disposition) any Common Stock
        or
        securities convertible into Common Stock (collectively, the “Additional Shares”)
        entitling any person to acquire shares of Common Stock, at an effective price
        per share less than the then effective Exercise Price (such lower price,
        the
“Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (if
        the holder of the Additional Shares so issued shall at any time, whether
        by
        operation of purchase price adjustments, reset provisions, floating conversion,
        exercise or exchange prices or otherwise, or due to warrants, options or
        rights
        per share which are issued in connection with such issuance, be entitled
        to
        receive shares of Common Stock at an effective price per share which is less
        than the then effective Exercise Price, such issuance shall be deemed to
        have
        occurred for less than the Exercise Price on such date of the Dilutive
        Issuance), then the Exercise Price shall be reduced, concurrently with such
        Dilutive Issuance, to a price (calculated to the nearest cent) determined
        by
        multiplying such Exercise Price by a fraction, (A) the numerator of which
        shall
        be (1) the number of shares of Common Stock outstanding immediately prior
        to
        such Dilutive Issuance plus (2) the number of shares of Common Stock which
        the
        aggregate consideration received or to be received by the Company for the
        total
        number of Additional Shares so issued would purchase at such Exercise Price;
        and
        (B) the denominator of which shall be the number of shares of Common Stock
        outstanding immediately prior to such Dilutive Issuance plus the number of
        such
        Additional Shares so issued. Such adjustment shall be made whenever such
        Additional Shares are issued. Notwithstanding the foregoing, no adjustments
        shall be made under this Section 3.4 in respect of an Exempt Issuance. “Exempt
        Issuance” means the issuance of (a) shares of Common Stock or options to
        employees, officers or directors of the Company pursuant to any stock or
        option
        plan duly adopted for such purpose by a majority of the non-employee members
        of
        the Board of Directors of the Company or a majority of the members of a
        committee of non-employee directors established, (b) securities exercisable
        or
        exchangeable for or convertible into shares of Common Stock issued and
        outstanding on the Commencement Date, provided that such securities have
        not
        been amended since the Commencement Date to increase the number of such
        securities or to decrease the exercise, exchange or conversion price of such
        securities, (c) securities issued pursuant to acquisitions or strategic
        transactions, including but not limited to joint ventures and other strategic
        partnerships, approved by a majority of the disinterested directors of the
        Company and (d) securities issued to a bank or other financial institution
        in
        connection with a loan transaction provided that the issuance of the securities
        is not primarily for fundraising purposes and is approved by a majority of
        the
        disinterested directors of the Company.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      5. AMENDMENT
        OF SECTION 8. 
        Section
        8 of the Warrant is hereby deleted and replaced in its entirety by the
        following:

       

      Rights
        Applicable to the Warrant Shares.
        The
        parties hereby acknowledge and agree that the Shares are “Registrable
        Securities” pursuant to the Registration Rights Agreement.

       

      6. AMENDMENT
        OF SECTION 10.1. 
        Section
        10.1 of the Warrant is hereby deleted and replaced in its entirety by the
        following:

       

      Waivers
        and Amendments.
        This
        Warrant or any provisions hereof may be changed, waived, discharged or
        terminated only by a statement in writing signed by the Company and by Warrant
        Holders holding a majority of the then outstanding Warrants issued in a series
        of financings pursuant to the Agreement and the New Purchase
        Agreements.

       

      7. AMENDMENT
        OF SECTION 10.2. 
        Section
        10.2 of the Warrant is hereby amended such that all references to the “State of
        Idaho” shall be replaced with the “State of New York” and all references to the
“City of Boise, Idaho” shall be replaced with the “City of New York, State of
        New York.”

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      8. NO
        OTHER AMENDMENT.
        Except
        as specifically amended by this Amendment, the Warrant shall continue in
        full
        force and effect. In the event of any conflict between the terms of this
        Amendment and the Warrant, the terms of this Amendment shall govern and control.
        

       

      9. GOVERNING
        LAW. This
        Amendment shall be governed by and construed under the laws of the State
        of New
        York as applied to agreements among New York residents entered into and to
        be
        performed entirely within New York. 

       

      10. COUNTERPARTS.
        This
        Amendment may be executed in any number of counterparts, each of which shall
        be
        deemed an original, but all of which together shall constitute one and the
        same
        instrument. 

       

      11. SEVERABILITY.
        If one
        or more provisions of this Amendment are held to be unenforceable under
        applicable law, such provision shall be excluded from this Amendment and
        the
        balance of the Amendment shall be interpreted as if such provision were so
        excluded and shall be enforceable in accordance with its terms.

       

      12. ENTIRE
        AGREEMENT.
        This
        Amendment, together with the Warrant (including the Appendices and Exhibits
        thereto) and the other agreements executed pursuant hereto and thereto,
        constitutes the full and entire understanding and agreement between the parties
        with regard to the subjects hereof and thereof.

       

      [REMAINDER
        OF PAGE INTENTIONALLY LEFT BLANK]

      
        
          
            sd-381217 

          

          
          

        

        
          
          

          
            

          

        

        
          
          

          
          

        

      

      IN
        WITNESS WHEREOF, the
        parties have executed this First Amendment to Warrant Agreement as of the
        date
        first written above.

       

      SELLER:

       

      

       

      By:
        ___________________________________

      Name:
        _________________________________

      Title:
        __________________________________

       

      WARRANT
        HOLDER:

       

      _______________________________________

        (Name
        of
        Warrant Holder)

       

      By:
        ____________________________________

      Name:
        __________________________________

      Title:
        ___________________________________

       

       

      [REMAINDER
        OF PAGE INTENTIONALLY LEFT BLANK

      SIGNATURE
        PAGES OF WARRANT HOLDER TO FOLLOW]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]